Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
breast cancer
Mar 30, 2024, 11:42 |
Blog
Laura Esserman: An important new interdisciplinary meeting, RISE UP for Breast Cancer
Laura Esserman, Principal Investigator at The WISDOM Study, shared a post on LinkedIn: "I am excited…
Mar 27, 2024, 10:07 |
Insight
Piotr Wysocki: No benefit of continuing CDK4/6i beyond progression in advanced ER+/HER2- breast cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 27, 2024, 00:34 |
Blog
Todd Scarbrough: Evidence accumulates to give radiation oncology boost the boot in breast cancer whenever possible
Todd Scarbrough, Radiation Oncologist at Northeast Alabama Regional Medical Center, shared on X/Twitter: “Evidence accumulates to…
Mar 26, 2024, 19:04 |
Societies
Federica Giugliano: I am happy to be awarded by ESMO with a merit travel grant to attend ESMO Breast Cancer 2024 in Berlin
Federica Giugliano, Research Fellow at Gustave Roussy Institute, shared on LinkedIn: “I am happy to…
Mar 26, 2024, 18:39 |
Career
Lisa Newman Awarded the 2024 ASCO Gianni Bonadonna Breast Cancer Award
The American Society of Clinical Oncology (ASCO) has announced Lisa Newman, MD, MPH, FASCO, as the recipient…
Mar 26, 2024, 05:36 |
Blog
Marjolein Smidt: European Breast Cancer Conference - Day 2
Marjolein Smidt, Professor of Surgical Oncology at Maastricht UMC+, recently posted on LinkedIn: "European Breast…
Mar 26, 2024, 04:50 |
Insight
The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer - Dana-Farber's Breast Oncology Center
Dana-Farber's Breast Oncology Center shared on X/Twitter: "Listen to the latest ASCO podcast where Dr.…
Mar 25, 2024, 07:01 |
Opinion
Francisco J. Esteva: It is important to understand the treatment of early breast cancer must be individualized
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Mar 23, 2024, 23:31 |
Blog
Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn: “Excited to see…
Mar 23, 2024, 23:01 |
Blog
Maryam Lustberg: In honor of PCDI’s founder Anne Loeser this piece stands as a heartfelt tribute to her legacy following her passing on October 10, 2023 from metastatic breast cancer
47
48
49
50
51
All:
2589
Posts:
481 - 490
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube